Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gracell Biotechnologies Inc ADR (GRCL)

Gracell Biotechnologies Inc ADR (GRCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gracell Biotechnologies Inc ADR Building 12 Block B Phase II Biobay Industrial Park 218 Sangtian St. Suzhou F4 215123 CHN

www.gracellbio.com P: 86-512-6262-6701

Description:

Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company. It involved in discovering and developing breakthrough cell therapies to address unmet medical needs in the treatment of cancer. Gracell Biotechnologies Inc. is based in SUZHOU, China.

Key Statistics

Overview:

Market Capitalization, $K 744,950
Enterprise Value, $K 557,090
Shares Outstanding, K 72,678
Annual Sales, $ 0 K
Annual Net Income, $ -88,080 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,270 K
EBIT, $ -60,680 K
EBITDA, $ -52,160 K
60-Month Beta -0.33
% of Insider Shareholders 28.00%
Float, K 52,328
% Float 72.00%
Short Volume Ratio 0.26

Growth:

1-Year Return 390.43%
3-Year Return -54.91%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 11/13/23
Next Earnings Date 03/11/24
Earnings Per Share ttm -1.05
EPS Growth vs. Prev Qtr 66.67%
EPS Growth vs. Prev Year 72.22%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GRCL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -37.41%
Return-on-Assets % -31.24%
Profit Margin % 0.00%
Debt/Equity 0.06
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.35
Book Value/Share 3.06
Interest Coverage -88.88
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar